Literature DB >> 11122779

Beyond cholesterol lowering: deciphering the benefits of dietary intervention on cardiovascular diseases.

V A Mustad1, P M Kris-Etherton.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11122779     DOI： 10.1007/s11883-000-0044-x

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  21 in total

1.  The Oslo diet-heart study. Eleven-year report.

Authors:  P Leren
Journal:  Circulation       Date:  1970-11       Impact factor: 29.690

2.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

3.  Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.

Authors: 
Journal:  Br Med J       Date:  1971-12-25

Review 4.  Functional food science and the cardiovascular system.

Authors:  G Hornstra; C A Barth; C Galli; R P Mensink; M Mutanen; R A Riemersma; M Roberfroid; K Salminen; G Vansant; P M Verschuren
Journal:  Br J Nutr       Date:  1998-08       Impact factor: 3.718

5.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Authors: 
Journal:  N Engl J Med       Date:  1998-11-05       Impact factor: 91.245

6.  WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators.

Authors: 
Journal:  Lancet       Date:  1984-09-15       Impact factor: 79.321

7.  Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

Authors:  V Manninen; M O Elo; M H Frick; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen
Journal:  JAMA       Date:  1988-08-05       Impact factor: 56.272

8.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

9.  Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.

Authors:  M de Lorgeril; S Renaud; N Mamelle; P Salen; J L Martin; I Monjaud; J Guidollet; P Touboul; J Delaye
Journal:  Lancet       Date:  1994-06-11       Impact factor: 79.321

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245
View more
  1 in total

1.  Effect of the prolonged high-fat diet on the fatty acid metabolism in rat blood and liver.

Authors:  Natalia V Zhukova; Tatyana P Novgorodtseva; Yulia K Denisenko
Journal:  Lipids Health Dis       Date:  2014-03-16       Impact factor: 3.876
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.